Non-Discretionary Share Buyback Programme

RNS Number : 1422Q
RELX PLC
16 February 2023
 

16 February 2023

ISSUED ON BEHALF OF RELX PLC

Announcement of Non-Discretionary Share Buyback Programme

RELX PLC (the "Company") announces in compliance with the UK and EU Market Abuse Regulations that it will implement an irrevocable, non-discretionary programme to repurchase its ordinary shares between 16 February 2023 and 19 April 2023 (the "Programme"), with a spend in this period of £200 million. This follows the successful completion of a £150 million non-discretionary programme on 13 February 2023. Both programmes are part of the £800 million to be deployed on share buybacks in 2023, as announced on 16 February 2023.

The purpose of the Programme is to reduce the capital of the Company and it intends that shares purchased will be held in treasury.

Any share purchases will be made by the Company within certain pre-set parameters and in accordance with the general authority of the Company to repurchase shares granted by shareholders at the Company's Annual General Meeting held on 21 April 2022 which, taking into account shares purchased subsequent to this meeting, permits the Company to purchase no more than 177.0 million ordinary shares. Any share purchases effected by the Company will be in accordance with the UK and EU Market Abuse Regulations and Chapter 12 of the Listing Rules.

The Company has entered into an agreement with J.P. Morgan Securities plc ("JPMS plc") under which it has issued irrevocable instructions to JPMS plc to manage the Programme. JPMS plc will carry out the Company's instructions through the acquisition of ordinary shares in the Company for subsequent repurchase by the Company. JPMS plc will make its trading decisions under the Programme independently of, and uninfluenced by, the Company.

-ENDS-

Enquiries

Colin Tennant (Investors)

Tel : +44 (0)20 7166 5751

Paul Abrahams (Media)

Tel : +44 (0)20 7166 5724

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSEAPAKFASDEEA

Companies

Relx plc (REL)
UK 100

Latest directors dealings